This report describes the results of an 11-laboratory study to determine if a cefoxitin broth microdilution MIC test could predict the presence of mecA in staphylococci. Using breakpoints of <4 g/ml for mecA-negative and >6 or 8 g/ml for mecA-positive isolates, sensitivity and specificity based on mecA or presumed mecA for Staphylococcus aureus at 18 h of incubation were 99.7 to 100% in three cation-adjusted Mueller-Hinton broths tested. For coagulase-negative strains at 24 h of incubation, breakpoints of <2 g/ml for mecA-negative and >4 g/ml for mecA-positive isolates gave sensitivity and specificity of 94 to 99% and 69 to 80%, respectively.The use of a cefoxitin disk test to detect staphylococci that are likely to contain the mecA gene has been widely advocated since the test was first suggested (3, 6) and has been adopted by antimicrobial susceptibility testing organizations worldwide (http://www.bsac.org.uk/_db/_documents/version_6.1.pdf, http: //www.srga.org/, http://www.clsi.org/). For laboratories that do not use disk diffusion as their primary testing method, performing disk diffusion requires additional expense and reagents. Consequently, we performed studies to determine if a cefoxitin broth microdilution MIC breakpoint would correlate with the presence of the mecA gene in staphylococci.Cation-adjusted Mueller-Hinton broths (CAMHB) from three manufacturers (BBL, BD Diagnostic Systems, Sparks, MD; Difco, BD Diagnostic Systems, Sparks, MD; and Oxoid, Basingstoke, Hampshire, England) (cation content adjusted if necessary), were used to prepare frozen microdilution panels containing cefoxitin concentrations of 0.5 to 32 g/ml (including 6 g/ml) and oxacillin concentrations of 0.06 to 16 g/ml (in BBL CAMHB only). The frozen panels were shipped to all participants, along with 30-g cefoxitin disks (BBL). Each laboratory used its current lot of Mueller-Hinton agar for disk diffusion testing. ). Additional strains were tested at the CDC, totaling 167 S. aureus isolates and 22 CoNS. The total number of strains tested in all labs was 479 S. aureus isolates and 204 CoNS. All results were read after both 18-h and 24-h incubations. Endpoints were read as the lowest concentration at which no visible growth was observed. At 18 h of incubation, 97.3% of the MIC quality control results (for S. aureus ATCC 29213) and 97.9% of the disk diffusion quality control results (for S. aureus ATCC 25923) were within the range considered acceptable by the Clinical and Laboratory Standards Institute (CLSI).After testing, all strains were shipped to the CDC for further analysis. PCR testing for mecA was performed as previously described (8) on the following strains: (i) any S. aureus strain for which the cefoxitin MIC was Ͻ16 g/ml in any of the three media tested (n ϭ 180); (ii) any S. aureus strain for which the cefoxitin MIC was Ͼ8 g/ml and the oxacillin MIC was Ͻ4 g/ml in any of the three media tested (n ϭ 5); and (iii) a sample of the 304 isolates (n ϭ 16 [5%]) for which the cefoxitin MIC was Ͼ8 g/ml and the oxacillin MIC was Ͼ2 g...